Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
April 28 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX: ALGORAE AND ZYDUS ENTER EXCLUSIVE COMMERCIAL AGREEMENT AGREEMENT FOR 10 PRODUCTS WITH ZYDUS LIFESCIENCES FOR AUSTRALIAN AND NEW ZEALAND MARKETS Further company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka